Profile
Els Hubloux currently works at Newton Biocapital Partners SRL, as Investment Partner from 2017.
Ms. Hubloux also formerly worked at Tc Land Expression SA, as Director, DeuterOncology SA, as Director, Capricorn Partners NV, as Senior Investment Manager from 2009 to 2012, KBC Securities NV, as Analyst in 2003, Abbott Group Ltd., as Principal, MyCartis NV, as Chief Financial Officer, Quest Management SA (Private Equity), as Senior Investment Manager from 2007 to 2009, QBIC Venture Partners BV, as Investment Partner from 2012 to 2016, and Quest for Growth NV, as Senior Investment Manager.
Ms. Hubloux received her undergraduate degree and Masters Business Admin degree from Vrije Universiteit Brussel.
Els Hubloux active positions
| Companies | Position | Start |
|---|---|---|
Newton Biocapital Partners SRL
Newton Biocapital Partners SRL Investment ManagersFinance Newton Biocapital Partners SPRL is an active manager which invests in companies located in Belgium, Netherlands, Germany, France and Japan. It participates in early stage and seed stage transactions and focuses on sectors such as Health Technology. | Private Equity Investor | 04/04/2017 |
Former positions of Els Hubloux
| Companies | Position | End |
|---|---|---|
QBIC Venture Partners BV
QBIC Venture Partners BV Investment ManagersFinance QBIC Venture Partners invests in companies located in Belgium. The firm targets companies operating in the fields of software, deeptech, healthtech and biotech industries. It provides financing for seed, early and later stage capital requirements. The firm also makes follow-on investments. | Private Equity Investor | 31/12/2016 |
Capricorn Partners NV
Capricorn Partners NV Investment ManagersFinance Capricorn Partners invests in companies located in Europe. The firm focuses on sectors such as digital, health and clean technologies. It participates in early and growth stage capital transactions. | Private Equity Investor | 23/05/2012 |
Quest Management SA (Private Equity)
Quest Management SA (Private Equity) Investment ManagersFinance Quest invests in both private and public equity throughout Europe, with a focus on the ICT and life sciences sectors. They favor countries including Belgium, the Netherlands, the UK and Germany. Their investment vehicle Quest for Growth is managed as a cross-over fund targeting late-stage unlisted companies as well as small- to mid-cap listed equity. Part of their assets is invested indirectly in venture and private equity funds. Quest follows a hands-off, growth-oriented investment approach which can be contrarian at times, and is driven by in-house fundamental research. They target companies with high-growth potential across a broad range of industrial sectors including biotechnology, healthcare, semiconductors, telecommunications, software, electronics, information technology and new materials. | Private Equity Investor | 21/10/2009 |
KBC Securities NV
KBC Securities NV Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 20/02/2003 |
DeuterOncology SA
DeuterOncology SA BiotechnologyHealth Technology Operates as a preclinical-stage biotechnology company which focuses on the development of first-in-class dual MET and RAS pathway inhibitor for targeted cancer therapies | Director/Board Member | - |
Training of Els Hubloux
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Quest for Growth NV
Quest for Growth NV Investment ManagersFinance Functions as a private equity fund | Finance |
Capricorn Partners NV
Capricorn Partners NV Investment ManagersFinance Capricorn Partners invests in companies located in Europe. The firm focuses on sectors such as digital, health and clean technologies. It participates in early and growth stage capital transactions. | Finance |
KBC Securities NV
KBC Securities NV Investment Banks/BrokersFinance Provides brokerage services | Finance |
Abbott Group Ltd.
Abbott Group Ltd. Building ProductsProducer Manufacturing Manufactures doors and timber products | Producer Manufacturing |
Vrije Universiteit Brussel
Vrije Universiteit Brussel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MyCartis NV
MyCartis NV BiotechnologyHealth Technology Develops technologies for healthcare personalization needs | Health Technology |
Tc Land Expression SA
Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Develops gene expression biomarkers for transplantation and auto-immune disorders | Commercial Services |
Quest Management SA (Private Equity)
Quest Management SA (Private Equity) Investment ManagersFinance Quest invests in both private and public equity throughout Europe, with a focus on the ICT and life sciences sectors. They favor countries including Belgium, the Netherlands, the UK and Germany. Their investment vehicle Quest for Growth is managed as a cross-over fund targeting late-stage unlisted companies as well as small- to mid-cap listed equity. Part of their assets is invested indirectly in venture and private equity funds. Quest follows a hands-off, growth-oriented investment approach which can be contrarian at times, and is driven by in-house fundamental research. They target companies with high-growth potential across a broad range of industrial sectors including biotechnology, healthcare, semiconductors, telecommunications, software, electronics, information technology and new materials. | Finance |
QBIC Venture Partners BV
QBIC Venture Partners BV Investment ManagersFinance QBIC Venture Partners invests in companies located in Belgium. The firm targets companies operating in the fields of software, deeptech, healthtech and biotech industries. It provides financing for seed, early and later stage capital requirements. The firm also makes follow-on investments. | Finance |
Newton Biocapital Partners SRL
Newton Biocapital Partners SRL Investment ManagersFinance Newton Biocapital Partners SPRL is an active manager which invests in companies located in Belgium, Netherlands, Germany, France and Japan. It participates in early stage and seed stage transactions and focuses on sectors such as Health Technology. | Finance |
DeuterOncology SA
DeuterOncology SA BiotechnologyHealth Technology Operates as a preclinical-stage biotechnology company which focuses on the development of first-in-class dual MET and RAS pathway inhibitor for targeted cancer therapies | Health Technology |
- Stock Market
- Insiders
- Els Hubloux
















